BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15645831)

  • 1. Ergotamine abuse. Do patients benefit from withdrawal?
    Tfelt-Hansen P; Krabbe A
    Cephalalgia; 1981 Mar; 1(1):29-32. PubMed ID: 15645831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular adaptation in migraineurs with chronic daily headache.
    Hering R; Gardiner I; Catarci T; Whitmarsh T; Steiner T; de Belleroche J
    Cephalalgia; 1993 Aug; 13(4):261-6. PubMed ID: 8397071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ergotamine and methysergide abuse in patients with migraine.
    Lucas RN; Falkowski W
    Br J Psychiatry; 1973 Feb; 122(567):199-203. PubMed ID: 4714835
    [No Abstract]   [Full Text] [Related]  

  • 4. Ergotamine abuse: results of ergotamine discontinuation, with special reference to the plasma concentrations.
    Ala-Hurula V; Myllylä V; Hokkanen E
    Cephalalgia; 1982 Dec; 2(4):189-95. PubMed ID: 7159921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of ergotamine-induced headache and ergotamine withdrawal on information processing.
    Evers S; Schmidt F; Bauer B; Voss H; Grotemeyer KH; Husstedt IW
    Psychopharmacology (Berl); 1999 Feb; 142(1):61-7. PubMed ID: 10102783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs.
    Hering R; Steiner TJ
    Lancet; 1991 Jun; 337(8755):1442-3. PubMed ID: 1675320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Rebound headache' from ergotamine withdrawal.
    Page H
    JAMA; 1981 Aug; 246(7):719. PubMed ID: 7253126
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Ergotamine-induced headaches.
    Wainscott G; Volans G; Wilkinson M
    Br Med J; 1974 Jun; 2(5921):724. PubMed ID: 4852779
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug management of adult vascular headaches (migraine and cluster headache): Part I--Treatment of the acute attack.
    Damasio H
    Iowa Med; 1984 Nov; 74(11):490-2. PubMed ID: 6511281
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolfenamic acid and ergotamine abuse.
    Ala-Hurula V; Myllylä VV; Hokkanen E; Tokola O
    Headache; 1981 Nov; 21(6):240-2. PubMed ID: 7309503
    [No Abstract]   [Full Text] [Related]  

  • 11. [Headache caused by analgesic and/or ergotamine abuse].
    Panconesi A; Del Bianco PL; Curradi C; Franchi G; Anselmi B; Andreini R
    Clin Ter; 1991 May; 137(3):169-83. PubMed ID: 1831085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up.
    Schnider P; Aull S; Baumgartner C; Marterer A; Wöber C; Zeiler K; Wessely P
    Cephalalgia; 1996 Nov; 16(7):481-5; discussion 461. PubMed ID: 8933992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ['Only ergotamine still helps'].
    Ferrari MD; Mulder LJ
    Ned Tijdschr Geneeskd; 1991 Jul; 135(27):1209-11. PubMed ID: 1861750
    [No Abstract]   [Full Text] [Related]  

  • 14. [Possibilities and limitations of the therapy of headache].
    Nattero G; Savi L
    Minerva Med; 1987 Jul; 78(14):1083-7. PubMed ID: 2885788
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of ergotamine abuse on psychological and cognitive functioning.
    Roon KI; Bakker D; van Poelgeest MI; van Buchem MA; Ferrari MD; Middelkoop HA
    Cephalalgia; 2000 Jun; 20(5):462-9. PubMed ID: 11037742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D2-receptor imaging with 123I-iodobenzamide SPECT in migraine patients abusing ergotamine: does ergotamine cross the blood brain barrier?
    Verhoeff NP; Visser WH; Ferrari MD; Saxena PR; van Royen EA
    Cephalalgia; 1993 Oct; 13(5):325-9. PubMed ID: 8242725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosing and administration of ergotamine tartrate and dihydroergotamine.
    Mathew NT
    Headache; 1997; 37 Suppl 1():S26-32. PubMed ID: 9009471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug abuse in chronic headache: a clinico-epidemiologic study.
    Granella F; Farina S; Malferrari G; Manzoni GC
    Cephalalgia; 1987 Mar; 7(1):15-9. PubMed ID: 3581158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated expression of peripheral serotonergic receptors in migraine and cluster headache by sumatriptan.
    Martelletti P; Stirparo G; Rinaldi C; Giacovazzo M
    Int J Clin Pharmacol Res; 1994; 14(5-6):165-75. PubMed ID: 7672873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New aspects of headache treatment].
    Pichler E
    Monatsschr Ohrenheilkd Laryngorhinol; 1966 Dec; 100(12):544-50. PubMed ID: 16114452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.